Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.clindermatol.2020.12.018 http://scihub22266oqcxt.onion/10.1016/j.clindermatol.2020.12.018 33972060!7836423!33972060     free     free     free       Clin+Dermatol 2021 ; 39 (1): 98-103 Nephropedia Template TP {{tp|p=33972060|t=2021. Is the BCG vaccine a useful tool against COVID-19?|pdf=|usr=}}{{33972060}} gab.com Text Is the BCG vaccine a useful tool against COVID-19 JO: Clin Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=33972060 #FOAvip The Bacillus Calmette-Guerin (BCG) vaccine has been used since 1921 initially for protection against tuberculosis. BCG acts through stimulation of cell-mediated adaptive immunity with activation of the Th1 cells and production of interferon gamma. Additionally, it is able to stimulate the immune system in a nonspecific manner, which results in effectiveness of the BCG against non-mycobacterial infections and in some malignant, autoimmune, and inflammatory diseases. Recently, its potential use in the fight against the coronavirus disease 2019 (COVID-19) pandemic has been suggested. This is based upon the concept of BCG-induced trained innate immunity-a memory-like response of the innate immune system that can realize greater protection in case of re-infection. This hypothesis represents a milestone in the potential use of the BCG vaccine in the fight with the novel coronavirus. Twit Text FOAVip Is the BCG vaccine a useful tool against COVID-19 ????Clin Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=33972060 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33972060 #FOAvip English Wikipedia <ref>{{Cite pmid|33972060}}</ref> Is the BCG vaccine a useful tool against COVID-19? #MMPMID33972060 Zhelezova G; Mateeva V; Mateev G Clin Dermatol 2021[Jan]; 39 (1): 98-103 PMID33972060show ga The Bacillus Calmette-Guerin (BCG) vaccine has been used since 1921 initially for protection against tuberculosis. BCG acts through stimulation of cell-mediated adaptive immunity with activation of the Th1 cells and production of interferon gamma. Additionally, it is able to stimulate the immune system in a nonspecific manner, which results in effectiveness of the BCG against non-mycobacterial infections and in some malignant, autoimmune, and inflammatory diseases. Recently, its potential use in the fight against the coronavirus disease 2019 (COVID-19) pandemic has been suggested. This is based upon the concept of BCG-induced trained innate immunity-a memory-like response of the innate immune system that can realize greater protection in case of re-infection. This hypothesis represents a milestone in the potential use of the BCG vaccine in the fight with the novel coronavirus. |*Adjuvants, Immunologic[MESH] |BCG Vaccine/*immunology[MESH] |COVID-19/mortality/*prevention & control[MESH] |Humans[MESH] |Immunity, Innate[MESH]Is the BCG vaccine a useful tool against COVID-19?(epmc).pdf DeepDyve Pubget Overpricing